Jeffrey A. Meckler was appointed CEO of Intec Pharma Ltd. Meckler was named vice chairman of the Intec Pharma board of directors in April 2017 and continues in that role.

Paul M. Bisaro was made president and CEO as well as a member of the board of directors of Impax Laboratories Inc.

Jeffrey Young has become chief financial officer, treasurer, and secretary of Juniper Therapeutics Inc.

Med Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.

Alicia Secor has been named president and CEO of Juniper Pharmaceuticals Inc., effective Aug. 1, 2016. Secor will also be appointed to the board of directors.

Grey Doyle is appointed CEO of Leading BioSciences Inc. Doyle, a long-standing member of Leading BioSciences’ executive management team and board of directors, previously served as chief operations officer and chief financial officer.

Virtus Pharmaceuticals Inc. – a specialty niche pharmaceutical company and part of the Linden Capital Partners portfolio – announced it launched Prometrium (Progesterone, USP Capsules), the company’s first branded product.

Fredrik Wiklund has been made chief operating officer of Bioniz Therapeutics Inc.

Yutaka Niihara, M.D., MPH, has been reapppointed CEO of Emmaus Life Sciences Inc. Dr. Niihara is co-founder and chairman of the company. Emmaus Life Sciences is engaged in the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases.

New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s […]